Articles In Press
Back to the articles list |
Back to browse issues page
Assessment of Serum Expression of lncRNA MHENCR, miR-425, and PI3K in Iranian Patients with Melanoma
1- National center for health insurance research, Tehran, Iran.
2- Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
3- Department of Medical Biotechnology, Zanjan University of Medical Science, Zanjan, Iran ,davoudibiotech@gmail.com
2- Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
3- Department of Medical Biotechnology, Zanjan University of Medical Science, Zanjan, Iran ,
Abstract: (8 Views)
Background and Objective: Melanoma is recognized as one of the most aggressive types of human cancer, arising from the uncontrolled growth of melanocytes. Recent research has emphasized the crucial role of non-coding RNAs in the development and progression of cancer. In this study, we investigated the expression patterns of lncRNA MHENCR, miR-425 and PI3K in 17 melanoma samples. Methods: In present study, we used real-time PCR to assess the expression levels of lncRNA MHENCR, miR-425 and PI3K in the serum of Iranian melanoma patients. β-actin and GAPDH were both used as controls.
Results: Real-time PCR analysis showed that the expression of lncRNA MHENCR in the serum samples of melanoma patients was increased 1.23-fold compared to the control group (p < 0.05), while the expression of miR-425 and PI3K was decreased by 0.828-fold and 0.795-fold, respectively (p < 0.05).
Conclusion: Changes in the expression of MHENCR, miR-425 and PI3K highlight their key roles in melanoma-related regulatory pathways and their potential as diagnostic, prognostic, and therapeutic targets.
Results: Real-time PCR analysis showed that the expression of lncRNA MHENCR in the serum samples of melanoma patients was increased 1.23-fold compared to the control group (p < 0.05), while the expression of miR-425 and PI3K was decreased by 0.828-fold and 0.795-fold, respectively (p < 0.05).
Conclusion: Changes in the expression of MHENCR, miR-425 and PI3K highlight their key roles in melanoma-related regulatory pathways and their potential as diagnostic, prognostic, and therapeutic targets.
Type of Study: Original Research Article |
Subject:
Life Science
Received: 2025/10/25 | Accepted: 2026/06/22
Received: 2025/10/25 | Accepted: 2026/06/22
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |